With demand for GLP-1 medications at an all-time high, many patients are finding themselves caught in a system that prioritizes access to prescriptions over quality of care. The result often means less flexibility in dosing, unmanaged side effects, and little to no support beyond the prescription itself, making it harder for patients to maintain long-term results.
Today, Ivim Health announces anew solution. GLP-1 Individualized Dosing (GLP-1 ID) is a precision dosing protocol designed to deliver real-time, responsive care to patients on GLP-1 therapy. Built on the foundation of Ivím's nationally recognized care model, GLP-1 ID combines real-time provider-guided dose adjustments with individualized, whole-patient support to establish a new standard for safety, effectiveness, and sustainability in obesity care.
"Every body is different, and that's especially true when it comes to how people respond to GLP-1 medications. While we offer fixed-dose protocols as well, it's much more difficult to work around side effects, sensitivities, or how quickly someone's body adjusts. Fixed-dose plans simply don't offer the flexibility many patients need. With GLP-1 ID, we're able to tailor the dose week by week based on how the patient is actually feeling and progressing. "
— Dr. Jessica Duncan, MD, Obesity Medicine Specialist, Ivim Health
The new GLP-1 ID protocol was developed in response to outcomes observed in a retrospective study published in Obesity Pillars (June 2025), which analyzed 1,131 patients treated through Ivím's virtual GLP-1 program.
While the study did not evaluate GLP-1 ID specifically, it validated the power of Ivím's individualized care model. These real-world insights inspired the development of GLP-1 ID as a way to scale and refine what worked: responsive care, dose flexibility, and a patient-first approach. GLP-1 ID takes this model even further by introducing a structured system for weekly dose adjustments, tailored to each patient's biology, symptoms, and goals.
About Ivim Health:
Ivim Health is a leading virtual healthcare provider specializing in individualized weight care and the treatment of cardiometabolic conditions such as obesity.
With more than 25,000 five-star reviews on Trustpilot, Ivim Health is recognized as a leading GLP-1 telehealth provider in the United States. Ivim Health has cared for over 470,000 patients across all 50 states and is the top-rated GLP-1 telehealth provider on Trustpilot, the leading global platform for verified healthcare and service reviews, with over 25,000 five-star reviews.